Trial ID or NCT#
The purpose of this trial is to determine whether treatment with valsartan will have beneficial effect in early hypertrophic cardiomyopathy (HCM) by assessing many domains that reflect myocardial structure, function and biochemistry.
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Contact us to find out if this trial is right for you.
Euan Ashley, MD, PhD